对于胃食道结癌的FLOT或CROSS,这个辩论已经结束了吗?
Bushra Shariff1, Rutika Mehta2
1Department of Internal Medicine, Moffitt Cancer Center, Tampa, FL, USA.
Chinese clinical oncology
|June 12, 2023
概括
胃食道结腺癌 (GEJ AC) 的发生率正在上升. 虽然手术是高级GEJ癌症的标准,但化学疗法和化学辐射等多模式治疗提供了可比的生存益处.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 胃食道结腺癌 (GEJ AC) 的发病率上升,与肥胖和GERD有关.
- 由于其侵略性,GEJ AC是癌症死亡的主要原因.
- 对于局部晚期GEJ癌症的最佳治疗方法仍在争论中,新辅助化疗 (CRT) 和外科化疗都是标准选择.
研究的目的:
- 审查GEJ癌症治疗策略的历史演变.
- 为了比较当前的标准治疗选择局部晚期GEJ癌症.
- 为未来GEJ癌症的治疗方向提供见解.
主要方法:
- 对具有里程碑意义的临床试验的审查,包括FLOT和CROSS研究.
- 对新辅助化学辐射 (CRT) 与外科手术期间化学疗法的分析.
- 讨论影响GEJ癌症治疗选择的因素.
主要成果:
- 在FLOT (外科化疗) 和CROSS (新辅助CRT) 试验中,整体存活率 (OS) 和无病存活率 (DFS) 的改善相似.
- 多模式治疗方法在局部先进的GEC中显示出优异的结果,与仅进行手术相比.
- 对局部晚期GEJ癌症的最终"黄金标准"治疗仍在讨论中.
结论:
- 对GEJ癌症的CRT和术后化疗之间的选择需要仔细考虑个体患者的因素.
- 对GEJ癌症的未来治疗策略正在发展,需要持续的研究.
- 个性化治疗选择对于优化GEJ腺癌的结果至关重要.
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Crossover Experiments
2.9K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.9K
Esophageal Varices-I: Introduction
203
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
203
Esophageal Varices-II: Clinical Features and Management
100
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
100


